Navigation Links
Mediware Completes Acquisition of Integrated Marketing Solutions
Date:10/31/2007

Acquisition enhances focus on Blood and Plasma Donor Centers

LENEXA, Kan., Oct. 31 /PRNewswire-FirstCall/ -- Mediware Information Systems, Inc., (Nasdaq: MEDW), a provider of ClosedLoop(TM) clinical systems for blood and medication management, announced that the Company has completed the acquisition of substantially all of the assets of Integrated Marketing Solutions (IMS). IMS is a provider of software products and services that enable blood and plasma donation centers to improve donor relationship management with powerful web based tools. In the transaction that was announced on October 16, 2007, Mediware's purchase agreement includes a cash payment of approximately $5.2M with an additional earn out opportunity based on operational performance.

"We are very excited to have this transaction complete," said Kelly Mann, Mediware's President and Chief Executive Officer. "IMS has an exceptional reputation within the industry -- one that is built from its experienced staff, powerful technology and responsive customer care."

Mann continued, "The addition of IMS enhances Mediware's vision for ClosedLoop(TM) management of the blood supply and enables our mutual clients with increased capabilities. It also provides our clients and investors a clear indication that our strategy is to invest in our capabilities and deliver growth."

The IMS software and services address the competitive nature of the blood supply market by enabling blood and plasma collection facilities with automated and online software to better manage relationships with donors, staff and hospitals.

"The IMS products create a logical interface with our existing technology," said Mann. "The integration of IMS's relationship portals, with the clinical management capabilities provided in LifeTrak, will provide end-to-end donor center support and a ClosedLoop environment that streamlines donor center efficiency."

The IMS product line includes the following products that can be licensed individually on a contract basis:

-- RecruitAssist: personalized online environment allowing blood centers

to manage their recruitment efforts and donors to view drive schedules,

schedule appointments, and review their donation histories.

-- CallAssist: tele-recruiting and Donor Relationship Management (DRM)

product that enables telerecruiting staff with all relevant donor

information including contact data, donation histories, loyalty program

status, mobile drive data and web activity.

-- OrderAssist: online supply and inventory manager that electronically

processes orders and tracks delivery status for blood centers and

hospitals.

-- QualityAssist: an online customer service environment facilitating

interaction and communication between donors and blood center staff.

-- CoordinatorAssist: loyalty-driven online software to help blood drive

coordinators plan and manage events at their companies or for their

organizations.

-- DriveAssist: online automated systems to help schedule, promote and

manage mobile blood drives.

-- SalesAssist: online sales force automation software to manage sales

activities, increase sales effectiveness and monitor business

performance.

Mediware has long been a leader in the clinical systems supporting donor centers and the Company's LifeTrak(R) product supports more than 65 facilities. LifeTrak, which includes LifeTrak Donor, LifeTrak Lab and LifeTrak Distribution, is 510(K) cleared as a medical device.

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site at http://www.mediware.com.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.


'/>"/>
SOURCE Mediware Information Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
7. Smoking Increases Risk of HIV Acquisition
8. Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
9. Integrated Disease Surveillance Project Soon In The Country
10. Integrated Child Development Scheme
11. Mumbai to Have Integrated Trauma Care Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting ... America. “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy Engestrom, ... , Nancy attributes her patriotic nature to her WWII veteran father. She says, ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma Alliance ( http://www.angioma.org ... angiomas, was awarded a grant from the Julian Grace Foundation to increase its ... more people with cavernous angioma than anywhere in the world. Most share a ...
(Date:12/7/2016)... Mateo, CA (PRWEB) , ... December 07, 2016 , ... ... San Francisco Peninsula region, is proud to announce new city-specific pages as part of ... services for the elderly, they often look, first, for local agencies serving their city. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... collaborate in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ... available in South Korea for emergency deployment in the event of a future ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
(Date:12/7/2016)... 7, 2016  Lannett Company, Inc. (NYSE: LCI ) ... Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 ... New York City . In addition, the ... Guggenheim Securities 4 th Annual Boston Healthcare Conference taking place ... ...
(Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
Breaking Medicine Technology: